This is a specific type of mole that appears on the side of the face. It can also affect the eyes and the skin around them. It's usually harmless, but doctors need to check it.
Every report comes from a Lived member, sent anonymously.
Have you had Laser Therapy for Ota's Nevus?
Ota's nevus, also called nevus of Ota or oculodermal melanocytosis, is a benign (noncancerous) birthmark that appears as a flat blue-gray, slate or brownish patch on the face. It usually affects one side, spreading across some combination of the forehead, temple, cheek, nose and the skin around the eye. In many people the pigment also reaches the eye itself, showing as gray or bluish spots on the white of the eye (the sclera), and it can occasionally involve the inside of the mouth. The patch itself causes no pain or itching, and for many people the main burden is how visible it is on the face. Its importance goes beyond appearance, though: when the pigment extends into the eye, it carries a higher risk of glaucoma and, rarely, a type of eye cancer called uveal melanoma. That is why the condition is managed by both skin and eye specialists.
Ota's nevus forms when pigment-producing cells called melanocytes, which normally travel to the skin's surface layer before birth, remain lodged in the deeper skin. Pigment seen through that depth looks blue-gray rather than brown. Researchers do not fully understand why this happens, and it is not caused by anything a parent or the person did. It is usually not inherited, although rare family cases have been described. It is uncommon, seen most often in people of East Asian descent, but it occurs in every ethnic group. It is about five times more common in females. Many cases are present at birth or appear in the first year of life; others first appear or darken around puberty, and some during pregnancy, which points to a role for hormones. The main risks connected with Ota's nevus relate to the eye. Extra pigment cells in the drainage area at the front of the eye can hinder fluid outflow and raise eye pressure. Pigment cells in the deeper layers of the eye are also the basis for a raised melanoma risk, estimated at roughly 1 in 400 over a lifetime in white people with eye involvement. That is still uncommon, but it is meaningfully higher than in the general population. Melanoma arising this way is more often reported in white people than in Asian people, and is usually diagnosed in adulthood.
A dermatologist or eye doctor can usually recognize Ota's nevus from its color, its location on one side of the face and the involvement of the white of the eye. A dermatoscope (a lighted magnifier) shows an even blue-gray pigment beneath the skin surface. Other conditions that can look similar include a Mongolian spot (a blue-gray birthmark that usually fades in early childhood and is rarely on the face), melasma (brown patches, typically on both cheeks), a blue nevus (a small raised mole) and darkening caused by certain medicines. A condition called acquired bilateral nevus of Ota-like macules, which appears in adulthood on both cheeks, does not involve the eye. Because the eye can be affected even when vision seems normal, diagnosis should include a full eye examination: vision, eye pressure measurement and a dilated look at the back of the eye. A skin biopsy is not routinely needed. It is reserved for areas that change, such as a new raised bump, a sore that does not heal or a change in color.
Treatment of the skin patch is optional and done for appearance, not because the patch is harmful. Pigment-targeting lasers are the main treatment. Q-switched lasers and newer picosecond lasers release energy in bursts so brief that they shatter the pigment in the deeper skin, and the body gradually clears the fragments. Lightening is gradual: most people need several sessions spaced months apart, and many achieve substantial or near-complete clearing. Results vary with the depth and darkness of the pigment, and studies are mostly observational. The main trade-offs are discomfort during treatment, temporary redness, and patches of skin that become darker or lighter after treatment, which usually settle over time but can persist. The pigment can return in a minority of people. Starting in early childhood has been linked to fewer sessions and fewer side effects, although some clinicians prefer to wait, and the decision often involves weighing anesthesia and comfort for a young child. Lasers treat only the skin; they do not remove pigment in the eye or change the eye risks.
Ota's nevus does not fade on its own. Its intensity may vary somewhat, and it can darken during puberty or pregnancy. For most people it remains a cosmetic concern that does not affect physical health or daily function. Some people, especially children and teenagers, find a visible facial mark affects confidence, and support or treatment for appearance is a reasonable choice. The most important long-term step is ongoing eye care. People whose pigment involves the eye are advised to have regular examinations by an eye doctor, including eye pressure checks for glaucoma and a dilated exam to look for melanoma. No guideline sets a fixed schedule, so the interval is usually agreed with the eye doctor based on how much of the eye is involved and age. The aim is to catch rising eye pressure or a growing tumor early, before vision is affected. Laser treatment of the skin does not replace these checkups.
See a dermatologist and an eye doctor if you or your child has a blue-gray or brownish patch on one side of the face or bluish spots on the white of the eye that have not been evaluated, and keep up the regular eye checks agreed with your eye doctor. Arrange a prompt eye appointment for new blurred or lost vision, distorted vision, eye pain or a bulging eye. See your dermatologist soon if part of the patch becomes raised, forms a bump, develops a sore that does not heal or changes color unevenly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Ota's Nevus is like, what's helped you, or ask the community a question.